This post is about the event study and the new diff-in-diff methods, but it isn’t about heterogenous treatment effects or differential timing. It’s more general than either of those things, which is why I think this post is probably broadly interpretable even if those topics are not ones you have felt the most confident about.
What do we use event studi…
